Alpha Paradigm Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.13M Buy
10,168
+8,426
+484% +$861K 0.47% 55
2022
Q3
$150K Sell
1,742
-18,466
-91% -$1.65M 0.07% 331
2022
Q2
$1.84M Buy
20,208
+19,840
+5,391% +$1.76M 0.76% 11
2022
Q1
$30K Buy
+368
New +$29K 0.01% 500
2021
Q3
Sell
-1,526
Closed -$119K 615
2021
Q2
$119K Buy
+1,526
New +$114K 0.04% 423
2021
Q1
Sell
-136
Closed -$11K 588
2020
Q4
$11K Buy
+136
New +$10.4K ﹤0.01% 401

Other funds holding MRK

Alpha Paradigm Partners's MRK Position: Q4 2022 in Review

Alpha Paradigm Partners increased its Merck (MRK) stake by 484% in Q4 2022, buying an estimated $861K and bringing the position to 10,168 shares worth $1.13M. The position accounts for 0.47% of the portfolio, ranked #55.

Alpha Paradigm Partners first reported a position in MRK in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.84M in Q2 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Alpha Paradigm Partners held 10,168 shares of Merck worth $1.13M as of Q4 2022.
  • Alpha Paradigm Partners bought 8,426 Merck shares in Q4 2022, an estimated $861K.
  • Merck made up 0.47% of Alpha Paradigm Partners's portfolio in Q4 2022, its #55 holding.
  • Alpha Paradigm Partners first reported a position in Merck in Q4 2020 and has held it in 6 quarters since.
  • Alpha Paradigm Partners's Merck position peaked at $1.84M in Q2 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.